tiprankstipranks
Advertisement
Advertisement

ALVO Stock Latest News

Alvotech TBA Spot Secondary; price range $3.75-$undefined
The FlyAlvotech TBA Spot Secondary; price range $3.75-$undefined
4h ago
ALVO
Alvotech announces termination of ATM Prospectus Supplement with Jefferies
PremiumThe Fly
Alvotech announces termination of ATM Prospectus Supplement with Jefferies
6h ago
JEF
ALVO
Alvotech Halts Use of ATM Prospectus Supplement While Keeping Jefferies Sales Agreement Intact
PremiumCompany Announcements
Alvotech Halts Use of ATM Prospectus Supplement While Keeping Jefferies Sales Agreement Intact
6h ago
6K
ALVO
Alvotech Wins FDA Review for Entyvio Biosimilar AVT16 as Q1 2026 Results Filed
PremiumCompany Announcements
Alvotech Wins FDA Review for Entyvio Biosimilar AVT16 as Q1 2026 Results Filed
7d ago
6K
ALVO
Alvotech announces FDA acceptance of AVT16 BLA for review
PremiumThe Fly
Alvotech announces FDA acceptance of AVT16 BLA for review
8d ago
ALVO
TEVA
Alvotech resubmits AVT05 BLAs to FDA
PremiumThe FlyAlvotech resubmits AVT05 BLAs to FDA
12d ago
RDY
ALVO
Alvotech Earnings Call Balances Setbacks and Momentum
Premium
Company Announcements
Alvotech Earnings Call Balances Setbacks and Momentum
27d ago
ALVO
Alvotech Clears Key FDA Inspection at Reykjavik Plant, Paving Way for 2026 BLA Resubmissions
Premium
Company Announcements
Alvotech Clears Key FDA Inspection at Reykjavik Plant, Paving Way for 2026 BLA Resubmissions
1M ago
6K
ALVO
Alvotech announces cGMP surveillance inspection of Reykjavik facility
PremiumThe Fly
Alvotech announces cGMP surveillance inspection of Reykjavik facility
1M ago
ALVO
Alvotech Earnings Call Balances Risk and Growth
PremiumCompany Announcements
Alvotech Earnings Call Balances Risk and Growth
1M ago
ALVO
Alvotech Announces General Counsel Transition After Six-Year Tenure
PremiumCompany Announcements
Alvotech Announces General Counsel Transition After Six-Year Tenure
1M ago
6K
ALVO
Alvotech Earnings Call: Growth Momentum Meets FDA Risk
PremiumCompany Announcements
Alvotech Earnings Call: Growth Momentum Meets FDA Risk
3M ago
ALVO
Alvotech price target lowered to $4 from $8 at Deutsche Bank
PremiumThe FlyAlvotech price target lowered to $4 from $8 at Deutsche Bank
3M ago
ALVO
Alvotech price target lowered to $4 from $5 at Barclays
Premium
The Fly
Alvotech price target lowered to $4 from $5 at Barclays
3M ago
ALVO
Alvotech: Regulatory Setbacks Priced In, Biosimilar Strength Supports Buy Rating Despite Lowered Target
Premium
Ratings
Alvotech: Regulatory Setbacks Priced In, Biosimilar Strength Supports Buy Rating Despite Lowered Target
3M ago
ALVO
Alvotech price target lowered to $6 from $10 at UBS
PremiumThe Fly
Alvotech price target lowered to $6 from $10 at UBS
3M ago
ALVO
Alvotech price target lowered to $4 from $5 at Barclays
PremiumThe Fly
Alvotech price target lowered to $4 from $5 at Barclays
3M ago
ALVO
Alvotech Posts Strong 2025 Growth, Adds Approvals and New CEO as Biosimilar Pipeline Expands
PremiumCompany Announcements
Alvotech Posts Strong 2025 Growth, Adds Approvals and New CEO as Biosimilar Pipeline Expands
3M ago
6K
ALVO
Is ALVO a Buy, Before Earnings?
PremiumPre-Earnings
Is ALVO a Buy, Before Earnings?
3M ago
ALVO
Alvotech Discloses Intra-Group Transfer of 2.7 Million Shares Within Aztiq Group
PremiumCompany AnnouncementsAlvotech Discloses Intra-Group Transfer of 2.7 Million Shares Within Aztiq Group
4M ago
6K
ALVO
Alvotech Hits Pivotal Milestone With Positive PK Data for Entyvio Biosimilar AVT80
Premium
Company Announcements
Alvotech Hits Pivotal Milestone With Positive PK Data for Entyvio Biosimilar AVT80
4M ago
6K
ALVO
Alvotech Strikes Sandoz Biosimilar Supply and Commercialization Deals in Canada, Australia and New Zealand
Premium
Company Announcements
Alvotech Strikes Sandoz Biosimilar Supply and Commercialization Deals in Canada, Australia and New Zealand
4M ago
6K
ALVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >